(Q53817058)

English

Serum vascular endothelial growth factor B is elevated in women with polycystic ovary syndrome and can be decreased with metformin treatment.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/26387747

Serum vascular endothelial growth factor B is elevated in women with polycystic ovary syndrome and can be decreased with metformin treatment. (English)

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/26387747

0 references

polycystic ovary syndrome

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

polycystic ovary

1 reference

based on heuristic

inferred from title

10

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/26387747

author name string

Feifei Cheng

1

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/26387747

Lu Zhao

2

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/26387747

Yuanyuan Wu

3

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/26387747

Tiantian Huang

4

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/26387747

Gangyi Yang

5

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/26387747

Zhanyu Zhang

6

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/26387747

Yijia Wu

7

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/26387747

Fang Jia

8

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/26387747

Jinlin Wu

9

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/26387747

Dongfang Liu

11

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/26387747

publication date

15 October 2015

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/26387747

Clinical Endocrinology

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/26387747

84

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/26387747

3

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/26387747

386-393

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/26387747

VEGF receptor signalling - in control of vascular function

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12950

21 January 2018

Targeting VEGF-B as a novel treatment for insulin resistance and type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12950

21 January 2018

Vascular endothelial growth factor B controls endothelial fatty acid uptake.

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12950

21 January 2018

Involvement of serum vascular endothelial growth factor family members in the development of obesity in mice and humans

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12950

21 January 2018

Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12950

21 January 2018

How metformin acts in PCOS pregnant women: insights into insulin secretion and peripheral action at each trimester of gestation

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12950

21 January 2018

Metformin administration modulates neurosteroids secretion in non-obese amenorrhoic patients with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12950

21 January 2018

Polycystic ovary syndrome: reviewing diagnosis and management of metabolic disturbances.

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12950

21 January 2018

Genetic downregulation of AMPK-alpha isoforms uncovers the mechanism by which metformin decreases FA uptake and oxidation in skeletal muscle cells

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12950

21 January 2018

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12950

21 January 2018

The prevalence and risk factors for glucose intolerance in young Korean women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12950

21 January 2018

Impaired insulin-stimulated phosphorylation of Akt and AS160 in skeletal muscle of women with polycystic ovary syndrome is reversed by pioglitazone treatment.

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12950

21 January 2018

Effects of exercise on insulin resistance and body composition in overweight and obese women with and without polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12950

21 January 2018

Elevated serum thioredoxin-interacting protein in women with polycystic ovary syndrome is associated with insulin resistance

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12950

21 January 2018

Prospective analysis of the insulin-resistance syndrome (syndrome X).

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12950

21 January 2018

Assessment of beta-cell function in humans, simultaneously with insulin sensitivity and hepatic extraction, from intravenous and oral glucose tests

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12950

21 January 2018

Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12950

21 January 2018

Oral glucose tolerance test indexes for insulin sensitivity and secretion based on various availabilities of sampling times

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12950

21 January 2018

Changes in insulin sensitivity and insulin release in relation to glycemia and glucose tolerance in 6,414 Finnish men

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12950

21 January 2018

Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12950

21 January 2018

Lipid-induced insulin resistance: unravelling the mechanism

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12950

21 January 2018

Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents.

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12950

21 January 2018

Metformin Inhibits Hepatic Gluconeogenesis Through AMP-Activated Protein Kinase-Dependent Regulation of the Orphan Nuclear Receptor SHP

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12950

21 January 2018

Role of AMP-activated protein kinase in mechanism of metformin action

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12950

21 January 2018

Resistance to Obesity by Repression ofVEGFGene Expression through Induction of Brown-Like Adipocyte Differentiation

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12950

21 January 2018

Identifiers

10.1111/CEN.12950

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/26387747

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/26387747

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53817058&oldid=1981065099"